HOME / Notice / News / EN
[2023 Customer Love Brand Award] Anti-aging solution ‘Just Ten Minutes’ is very popular NKCL Bio Group’s RK-NK100 anti-aging solution won the grand prize in the immune care platform category at the ‘2023 Customer Love Brand Awards’. The company holds patents and original technology for medium ad...
Acquired US patent for NK cell culture technology of NKCL Bio Group NKCL Bio Group (Chairman Shin Dong-hwa) announced that it had obtained a U.S. patent for NK cell culture technology. Recently, NKCL Bio Group successfully completed pre-clinical trials on the company's NK cell therapy pipeline for li...
[China-ROK (Changchun) International Cooperation Demonstration Zone Project, spurs the construction of a medical complex] A delegation from the 'China-ROK (Changchun) International Cooperation Demonstration Zone' (hereafter referred to as Changchun Demonstration Zone), an international industrial coo...
NKCL Bio Group, a high-tech biopharmaceutical manufacturing company, has obtained a cell processing facility permit under the Advanced Regenerative Bio Act from the Ministry of Food and Drug Safety(MFDS). Accordingly, NKCL Bio Group announced on the 24th that it will focus on the cell therapy busines...
NKCL Bio Group (Chairman Donghwa Shin), an advanced biopharmaceutical manufacturing company, announced on the 22nd that it had obtained permission for a cell processing facility based on the advanced regenerative bio method from the KFDA. NKCL Bio Group acquired permission to 'Manufacturing of Advanc...